SASAKAWA MEMORIAL HEALTH FOUNDATION
Japanese
Character sizeLargeSmall

WHO Goodwill Ambassador's Newsletter For The Elimination Of Leprosy

LEPROSY WISH LIST

Dr. Marcos Virmond
President
International Leprosy Association

A NON-TERANOGENIC THALIDOMIDE.

This dreaded drug is a marvellous choice for treating Type 2 leprosy reactions. However, its strong potential to cause deformity in babies makes it a stigmatized drug.

AN EFFECTIVE IMMUNOMODULATOR TO TREAT TYPE 1 and TYPE 2 LEPROSY REACTIONS.

Leprosy without reaction would be almost a harmless disease.

A POTENT NERVE FIBER REGENERATION INDUCER THROUGH FIBROTIC TISSUE.

Nerves in leprosy retain their potential to regenerate. The problem is to make a path through intense fibrotic areas to reach the end organs (muscle or skin).

A SIMPLE SERUM TEST TO DETECT APPROCHING TYPE 1 AND TYPE 2 LEPROSY REACTIONS.

If you could predict a leprosy reaction ahead of its onset, it would be easier to treat it and prevent deformities.

AN END TO LEPROSY STIGMA.

Stigma is a top reason for delayed diagnosis, maintenance of the infectious chain and onset of disabilities and deformities. I would like to see the elimination of the stigma associated with the disease.